Aandeel 6609 SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Shanghai HeartCare Medical Technology Corporation Limited

Aandelen

6609

CNE100004MN5

Beurs gesloten - Hong Kong S.E.
Andere beurzen
 08:59:40 27-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
16,06 HKD -1,59% Intraday-grafiek van Shanghai HeartCare Medical Technology Corporation Limited -0,74% -46,02%
28/03 Shanghai HeartCare Medical Technology Corporation Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 CI
2023 Shanghai Heartcare Medical Technology Corporation Limited benoemt Xue Zongyu tot voorzitter van het Comité van Toezicht CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Shanghai HeartCare Offloads Stake in Medical Device Developer Shenji Medical
Shanghai Heartcare Medical Technology Corporation Limited Appoints Xue Zongyu as the Chairperson of the Supervisory Committee
Shanghai Heartcare Medical Technology Corporation Limited Announces Board Changes
Shanghai HeartCare Medical Technology Corporation Limited(SEHK:6609) dropped from S&P Global BMI Index
HeartCare Medical Technology's Loss Narrows in H1
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai HeartCare Medical Technology Corporation Limited Announces Nomination Committee Changes
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Shanghai Heartcare Medical Technology Corporation Limited Appoints Chen Shaoxiong as A Non-Executive Director
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Chen Gang as Non-Executive Director
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022
536,714 Unlisted Foreign Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.
6,731,890 Domestic Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.
24,963,954 H Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022.
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Ouyang Xiangyu as Non-Executive Director
Shanghai Heartcare Medical Technology Corporation Limited Appoints Wei Jiawei as an Executive Director
Shanghai HeartCare Medical Technology Corporation Limited Voluntary Receives Approval from the National Medical Products Administration for registration application for LAA Occluder
Shanghai Heartcare Medical Technology Corporation Limited Receives the Approvals from the National Medical Products Administration of the PRC for the Registration Applications for the Aspiration Catheter and Support Catheter
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 6609
  4. Nieuws Shanghai HeartCare Medical Technology Corporation Limited
  5. Andere talen